Sascha
Glanemann
Glanemann
Member of the Board / CEO
Sascha
Glanemann
Glanemann
Member of the Board / CEO
In the industry since 2003, in the company since 2025:
- General Manager Absorbest GmbH
- General Manager DACH Urgo GmbH
- Managing Director & Cluster Head Specialty Medicines Teva GmbH
Thomas
Milz
Milz
Member of the Board / CPO
Thomas
Milz
Milz
Member of the Board / CPO
In the industry since 1991, in the company from 1991 to 1996 and again since 1997:
- Director Market Access (UCB Pharma GmbH)
- Director Marketing (Schwarz Pharma Deutschland GmbH)
- Product Manager & Head of Marketing Vascular (Schwarz Pharma Deutschland GmbH)
Thomas
Zimmermann
Zimmermann
Member of the Board / CFO
Thomas
Zimmermann
Zimmermann
Member of the Board / CFO
In the pharma industry since 2011, in the company since 2022
- Finance Director DACH, Galderma Laboratorium GmbH
- Head of Finance, J.W. Ostendorf GmbH & Co. KG
- Tax Advisor, Certified Public Accountant, Ernst Young GmbH
Dr. Matthias
Wiedenfels
Wiedenfels
Chairman of the Supervisory Board
Dr. Matthias
Wiedenfels
Wiedenfels
Chairman of the Supervisory Board
On the Supervisory Board since: April 2021
Elected until 2027
- Lawyer and serial entrepreneur
- Chief Executive Officer, Perspix Biotech GmbH
- Member of the Executive Board, BioMedion AG
Olaf
Elbracht
Elbracht
Vice Chairman of the Supervisory Board
Olaf
Elbracht
Elbracht
Vice Chairman of the Supervisory Board
On the Supervisory Board since: April 2021
Elected until: 2027
-
Management Consultant,
-
Vice President Global Business Services Finance, UCB Pharma S.A.,
-
Chief Financial Officer, Schwarz Pharma,
-
Audit Manager, Deloitte GmbH
Dr. Martin
Albert
Albert
Prague, Czech Republic
Dr. Martin
Albert
Albert
Prague, Czech Republic
Julie
Ross
Ross
Zürich, Switzerland
Julie
Ross
Ross
Zürich, Switzerland
Anant Anand
Atal
Atal
Prague, Czech Republic
Anant Anand
Atal
Atal
Prague, Czech Republic